High dose intravenous immunoglobulin treatment: Mechanisms of action

被引:44
|
作者
Boros, P
Gondolesi, G
Bromberg, AS
机构
[1] Mt Sinai Sch Med, Recanati Miller Transplantat Inst, New York, NY 10029 USA
[2] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA
关键词
D O I
10.1002/lt.20594
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Intravenous immunoglobulin (IVIg) treatment was introduced as replacement therapy for patients with antibody deficiencies, but evidence suggests that a wide range of immune-mediated conditions could benefit from IVIg. The immunoglobulins are precipitated from human plasma by fractionation methods. In conclusion, the differences in basic fractionation methods and the addition of various modifications for purification, stabilization, and virus inactivation result in products significantly different from each other.
引用
收藏
页码:1469 / 1480
页数:12
相关论文
共 50 条
  • [1] Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders
    Larroche, C
    Chanseaud, Y
    de la Pena-Lefebvre, PG
    Mouthon, L
    BIODRUGS, 2002, 16 (01) : 47 - 55
  • [2] Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia
    Crow, Andrew R.
    Song, Seng
    Siragam, Vinayakumar
    Lazarus, Alan H.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (05) : 710 - 713
  • [3] Mechanisms of Intravenous Immunoglobulin Action in the Treatment of Autoimmune Disorders
    Claire Larroche
    Youri Chanseaud
    Paloma Garcia de la Pena-Lefebvre
    Luc Mouthon
    BioDrugs, 2002, 16 : 47 - 55
  • [4] Mechanisms of action of intravenous immunoglobulin
    Chaigne, Benjamin
    Mouthon, Luc
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (01) : 45 - 49
  • [5] Intravenous immunoglobulin: mechanisms of action
    Williams, PE
    INTRAVENOUS IMMUNOGLOBULINS IN THE THIRD MILLENNIUM, 2004, : 393 - 397
  • [6] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN (HDIVIG) TREATMENT OF IMMUNE-MEDIATED BLOOD CYTOPENIAS - MECHANISMS OF ACTION, INDICATIONS AND RESULTS
    AYMARD, JP
    FERRY, R
    JANOT, C
    SCHOONEMAN, F
    STREIFF, F
    ANNALES DE MEDECINE INTERNE, 1990, 141 (08): : 689 - 697
  • [7] Successful treatment of scleromyxoedema with high dose intravenous immunoglobulin
    Karim, A
    Lawlor, F
    Black, MM
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (03) : 317 - 318
  • [8] Treatment of childhood dermatomyositis high dose intravenous immunoglobulin
    Vedanarayanan, V
    Subramony, SH
    Ray, LI
    Evans, OB
    PEDIATRIC NEUROLOGY, 1995, 13 (04) : 336 - 339
  • [9] Successful treatment of dermatomyositis with high-dose intravenous immunoglobulin
    Kuwano, Y
    Ihn, H
    Yazawa, N
    Kakinuma, T
    Asahina, A
    Kikuchi, K
    Tamaki, K
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (02) : 158 - 159
  • [10] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN TREATMENT IN GRAVES OPHTHALMOPATHY
    ANTONELLI, A
    SARACINO, A
    ALBERTI, B
    CANAPICCHI, R
    CARTEI, F
    LEPRI, A
    LADDAGA, M
    BASCHIERI, L
    ACTA ENDOCRINOLOGICA, 1992, 126 (01): : 13 - 23